Treatment Resistance

The Treatment Resistance research group are using next-generation sequencing on plasma DNA and single-cell transcriptional profiling to interrogate treatment resistance.

Professor Gert Attard, UCL Cancer Institute
Professor Gert Attard, MD PhD FRCP

Professor of Medical Oncology

UCL Cancer Institute

Navigate to Prostate cancer ‘fingerprint’ detected in blood sample
Prostatic adenocarcinoma with perineural invasion

Prostate cancer ‘fingerprint’ detected in blood sample

Scientists at UCL have developed a new test to identify the earliest genetic changes of prostate cancer in blood: a process which could allow doctors to see if cancers have spread, monitor tumour behaviour and enable better treatment selection.

10 March 2020

Attard Lab | Treatment Resistance Group
Professor Gert Attard, UCL Cancer Institute

Attard Lab | Treatment Resistance Group

Prof. Attard's team are defining motion pictures of high-resolution molecular snap-shots at multiple time-points in disease evolution as cancers respond and subsequently become resistant to treatment.

Attard Lab UCL Treatment Resistance Research Group

Contact

For enquiries from prospective students and postdoctoral researchers, contact:

Basic silhouette in a circle, in light grey

Georgie Perry

PA to Professor Gert Attard

Click to email. ci.director_admin@ucl.ac.uk